Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
- 30 November 2010
- journal article
- review article
- Published by Wiley in European Journal of Neurology
- Vol. 18 (5) , 680-685
Abstract
To review the treatment and mechanisms underlying the increased prevalence of seizures associated with multiple sclerosis (MS). We carried out an extensive review of the literature pertaining to seizures in MS. We propose that an increase in interleukin-18, and its associated induction of indoleamine 2, 3-dioxygenase and quinolinic acid, mediates seizure activity in MS at least in part via an increase in interferon-gamma (IFNg). Increased kynurenine pathway activity decreases the availability of serotonin and melatonin. Increases in blood-brain barrier and circumventricular organ permeability are linked to these changes. Antiepileptic drugs modulate wider MS symptomatology, interacting with melatonin and vitamin D3. This manuscript provides a framework for the wider understanding and treatment of seizures in MS and wider MS symptomatology.Keywords
This publication has 50 references indexed in Scilit:
- Induction of Hypertension and Peripheral Inflammation by Reduction of Extracellular Superoxide Dismutase in the Central Nervous SystemHypertension, 2010
- CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depressionMolecular Psychiatry, 2009
- Valproic acid induces functional heat‐shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylationJournal of Neurochemistry, 2009
- Seizures in Patients with Multiple SclerosisCNS Drugs, 2009
- The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in miceJournal of Clinical Investigation, 2009
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunityJournal of Experimental Medicine, 2009
- Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunityProceedings of the National Academy of Sciences, 2009
- Epilepsy and Cognitive Impairments in Alzheimer DiseaseArchives of Neurology, 2009
- Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administrationJournal of Neuroimmunology, 2008
- Neuronal Peroxisome Proliferator-Activated Receptor γ Signaling: Regulation by Mood-Stabilizer ValproateJournal of Molecular Neuroscience, 2008